Rey-Giraud Agnes
- SEC CIK
- 0001235685
No open-market purchases or sales filed in the past year.
Current role at each company
- GDRX GoodRx Holdings, Inc.Directoras of Jun 17, 2026
- UPHL UpHealth, Inc.Directoras of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rey-Giraud Agnes as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
UPHL UpHealth, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 (view filing) | May 21 | 17 daysLate | Rey-Giraud AgnesDirector | SSale | −13.3K | $0.6004 | −$7.97K | −11.6%101.1K after | 2 lots |
GDRX GoodRx Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14-16 | 2 days | Rey-Giraud AgnesDirector | SSaleClass A Common Stock | −25.0K | $45.01 | −$1.13M | −100.0%0 after | 3 lots |
| Sep 9, 2021 (view filing) | Sep 7 | 2 days | Rey-Giraud AgnesDirector | SSaleClass A Common Stock | −54.4K | $41.56 | −$2.26M | −100.0%0 after |